Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Opinion

Xrayser: Unity is vital. Is now the time for the IPA to go up against the NPA?

This month, Xrayser talks about how the importance of unity in dealing with the government, and ahead of the much-deserved upcoming awards season.

CD Awards General Business

Opinion: When is a substitute not a substitute?

Once world-famous for the number of acronyms it had going on, pharmacy has started building an equally impressive collection of substitutes for existing things…

General Business People

Opinion: Pharmacies should be online for better patient access

As dispensing volumes grow and the demand for patient consultations increases, Harry McQuillan explores whether technology offers a solution so that both pharmacists and patients are happy…

Digital Services

Attention UK Pharmacy! Reward yourself at the C+D Awards. You deserve it

There are only weeks to go until the entry window for the C+D Awards slams shut, so add entering to the top of your to-do list and look forward to enjoying the evening.

CD Awards General Business

Opinion: Even the cleverest analysis will only prolong the medicine shortage

It’s been a while since I was dragged in front of the B-word, but thanks to the medicine shortage, here we are. Remember those grotesque days in 2016? All those odious ageing chancers on the make. What a cast of horrors. 

Businesses General Business

Will expanding access to naloxone OTC be the right move?

The government’s proposal to expand naloxone accessibility to OTC ran from January 24 2024 to March 6 2024. It marks a commendable effort to address the opioid crisis, says C+D’s Nana Ofori-Atta.

Substance abuse Public Health

Opinion: Antisemitism ruling is illogical and disturbing

It was obvious to me that Mr Ali’s words were antisemitic and, although I have spent a lifetime defending pharmacists in fitness to practise cases, I found the Committee’s decision so disturbing that I complained to the Professional Standards Authority...

Crime Crime in pharmacy

One slight alteration could avert a crisis as medicine shortages deepen

Medication shortages are a worsening problem. But there is one small step that could be taken that would help towards a solution…

Businesses Money

Xrayser: Error! The page you requested cannot be found

This month, Xrayser talks about another IT fail by Pharmacy First as community pharmacy pushed through Maundy Thursday

General Business

Pharmacy First has left GPs with a “reliable service” for their patients

Pharmacy First has helped build trust throughout the community. Mubin Bux explains how more patients are proactively using the service

General Business Services

The crucial role of pharmacy professionals and their impact on primary care

Observed through his work, Adeem Azhar explains how pharmacy professionals are alleviating GP pressures…

General Business

Shaping the future: The evolving role of pharmacy professionals in primary care

The role of pharmacy professionals continues to expand and shape primary care. Adeem Azhar explores what this means for the future of healthcare.

General Business Services
See All
UsernamePublicRestriction

Register